PHOTOSENSITIVITY ASSOCIATED WITH ANTIPSYCHOTICS, ANTIDEPRESSANTS AND ANXIOLYTICS

Citation
Y. Harth et M. Rapoport, PHOTOSENSITIVITY ASSOCIATED WITH ANTIPSYCHOTICS, ANTIDEPRESSANTS AND ANXIOLYTICS, Drug safety, 14(4), 1996, pp. 252-259
Citations number
47
Categorie Soggetti
Toxicology,"Pharmacology & Pharmacy","Public, Environmental & Occupation Heath
Journal title
ISSN journal
01145916
Volume
14
Issue
4
Year of publication
1996
Pages
252 - 259
Database
ISI
SICI code
0114-5916(1996)14:4<252:PAWAAA>2.0.ZU;2-X
Abstract
Photosensitivity reactions evoked by systemic agents are the result of the effects of the agent combined with subsequent exposure to light. Photosensitivity induced by exogenous parenteral agents accounts for a n increasing portion of the total undesirable effects caused by enviro nmental chemicals. The exponential increase in the number of new drugs introduced each year may be one of the factors explaining the increas ed number of reports describing photosensitivity induced by exogenous agents. There are many reports of photosensitivity caused by antipsych otic and antidepressant agents. Although the majority of the research was focused on the photosensitising potential of chlorpromazine, other antipsychotics and antidepressants have been shown to cause cutaneous photosensitivity. An extensive drug history must be taken whenever a patient presents with a reaction limited to, or accentuated in, light- exposed areas. It should be remembered that these reactions may presen t with a wide morphological spectrum ranging from sunburn-like respons es to eczematous, lichenoid and even bullous lesions, resembling porph yria cutanea tarda. In order to properly diagnose photosensitivity to systemic drugs it is important to prove photosensitivity by phototesti ng and to rule out other causes of systemic photosensitivity such as s ystemic lupus erythematosus and porphyria cutanea tarda.